NFKB1 and neoplasm: Taken together with the results of the tumor immune evaluation (Fig. 6), PPA@aPD-L1 remolded the intratumoral immunosuppressive microenvironment by inhibiting the NF-κB and STAT3 pathways in tumor cells.